LG
TDOC icon

LaFleur & Godfrey’s Teladoc Health TDOC Stock Holding History

LaFleur & Godfrey’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,521
Closed -$326K – 134
2022
Q1 		$326K Sell
4,521
-63,258
-93% -$4.56M 0.04% 110
2021
Q4 		$6.22M Sell
67,779
-4,956
-7% -$592K 0.8% 39
2021
Q3 		$9.22M Buy
72,735
+16,435
+29% +$2.39M 1.27% 30
2021
Q2 		$9.36M Buy
56,300
+3,361
+6% +$545K 1.34% 28
2021
Q1 		$9.62M Buy
52,939
+17,478
+49% +$4.05M 1.87% 20
2020
Q4 		$7.09M Buy
+35,461
New +$7.21M 1.45% 28

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

LaFleur & Godfrey's TDOC Position: Q2 2022 in Review

LaFleur & Godfrey sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 4,521 shares — an estimated $326K sold.

LaFleur & Godfrey first reported a position in TDOC in Q4 2020 and held it in 6 quarters. The position peaked at $9.62M in Q1 2021. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • LaFleur & Godfrey reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • LaFleur & Godfrey sold 4,521 Teladoc Health shares in Q2 2022, an estimated $326K.
  • LaFleur & Godfrey first reported a position in Teladoc Health in Q4 2020 and held it in 6 quarters.
  • LaFleur & Godfrey's Teladoc Health position peaked at $9.62M in Q1 2021.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on LaFleur & Godfrey's 13F filing for Q2 2022, filed 26 Jul 2022.